39 results
8-K
EX-99.1
NMRD
Nemaura Medical Inc
17 Aug 23
Regulation FD Disclosure
8:30am
are significant. It has become imperative to national health, as well as healthcare budgets, that better, more innovative and sustainable management and prevention
8-K
EX-99.1
NMRD
Nemaura Medical Inc
27 Jun 23
Nemaura Medical Scales-Up Pilot Expansion of proBEATTM; 56 Corporations in the USA signed up for pilots, in June 2023
9:00am
into employers and insurers in the U.S. represents significant progress towards bringing more innovative diabetes care solutions to our target markets
8-K
EX-99.1
NMRD
Nemaura Medical Inc
14 Nov 23
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
12:00am
by pharmaceutical interventions using GLP-1 agonists such as Ozempic, Wegovy and Mounjaro. This innovative offering, featuring education, lifestyle
8-K
EX-99.1
NMRD
Nemaura Medical Inc
16 Aug 21
Results of Operations and Financial Condition
8:12am
partnerships. Diabetes is a worldwide health crisis, and our non-invasive, needle-free CGM is an innovative solution for patients with both Type 1 and Type
8-K
NMRD
Nemaura Medical Inc
10 Apr 24
Entry into a Material Definitive Agreement
4:16pm
and innovative research approach promise to bring fresh perspective and valuable experience to the Board.
Mr. Butt, age 51, brings more than 28 years
8-K
EX-99.1
86l91c44
15 Nov 21
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
9:31am
8-K
EX-99.1
d3s2z9d
28 Sep 21
Regulation FD Disclosure
4:10pm
8-K
EX-99.1
e37ozk5h0c 1r3hml5
15 Oct 19
Regulation FD Disclosure
4:05pm
10-Q
y17d08
11 Sep 14
Quarterly report
12:00am
424B5
z9irf7xl0sh5
28 Jul 20
Prospectus supplement for primary offering
7:54am
424B5
aqq4f
27 Jul 20
Prospectus supplement for primary offering
7:13pm
10-K
gvqflp49av5
23 Jun 15
Annual report
12:00am
424B5
ukooref0ytf32xyppit
23 Jul 21
Prospectus supplement for primary offering
4:28pm